Insulin Initiation and Adherence Behaviours: a Cross Sectional Survey of Indian HCPs & Patients With Type 2 Diabetes

Completed

• Conditions: Type 2 Diabetes
• Interventions: Other: No treatment given

• Registration Number: NCT06517784
• Lead Sponsor: Novo Nordisk A/S

Brief Summary

This is a cross-sectional study planned among patients with Type 2 Diabetes (T2D) and Health Care Providers (HCPs) who treat T2D patients. Study participants will be recruited through existing databases/panels to complete a 30-minute self-administered online survey. The purpose of the study is to understand the insulinization barriers and the insulin adherence behaviours of both HCPs and patients.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-07-05
• Study First Submitted: 2024-07-18
• Study First Submitted QC: 2024-07-18
• Study First Posted: 2024-07-24
• Status Verified: 2024-08
• Primary Completion: 2024-08-16
• Study Completion: 2024-08-16
• Last Update Submitted: 2024-08-27
• Last Update Posted: 2024-08-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 752

Inclusion Criteria

For patients

1. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
2. Male or female, age above or equal to 18 years at the time of signing informed consent.
3. Diagnosed with T2D
4. Currently seeing an HCP for T2D
5. Initiated on insulin within the past 12 months
6. Prescribed insulin on a permanent basis
7. Currently taking insulin via a vial and syringe or insulin pen

For HCP

1. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
2. Male or female, age above or equal to 18 years at the time of signing informed consent.
3. Primary care physician (PCP) with degree in internal medicine or general medicine, diabetologist with degree in internal medicine or general medicine plus diploma in diabetology, or endocrinologist
4. Has been in practice a minimum of 2 years
5. Diabetologist/endocrinologist: treats at least 50 T2D patients per month
6. PCP: treats at least 40 T2D patients per month
7. Currently initiates T2D patients on insulin
8. Treats 20 percent or more of T2D patients with insulin

Exclusion Criteria

1. Previous participation in this study. Participation is defined as having given informed consent in this study
2. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Health care providers	No treatment given	Health care providers who treat patients with type 2 diabetes
Patients	No treatment given	Patients with type 2 diabetes

Primary Outcome Measures

Name	Time	Method
The barriers toward insulin initiation among HCPs & patients	At time of data abstraction (Day 1)	Barriers to insulin initiation = Likert scale: 1=Strongly disagree, 5=Strongly agree

Trial Locations

Locations (1)

Novo Nordisk India; 🇮🇳 Bangalore, India